Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 3.26M $771.10M March 31, 2014
Citi 2.60M $710.59M Sept. 30, 2014
MORGAN STANLEY 2.34M $640.88M Sept. 30, 2014
Barclays 1.67M $394.53M March 31, 2014
SUSQUEHANNA INTERNATIONAL 1.40M $383.98M Sept. 30, 2014
UBS AG 1.40M $383.28M Sept. 30, 2014
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
Bank of America Corporation 1.29M $353.33M Sept. 30, 2014
JPMORGAN CHASE & CO 1.25M $340.28M Sept. 30, 2014
Archer Capital Management 980000 $81.15M March 31, 2012
JANE STREET 856074 $234.51M Sept. 30, 2014
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Credit Suisse AG 521495 $142.70M Sept. 30, 2014
Bank of Nova Scotia 456000 $103.54M Dec. 31, 2013
HAP Trading 438300 $7.49M Sept. 30, 2014
Churchill Management 432945 $118.47M Sept. 30, 2014
Mirae Asset Global Investments 408643 $105.23M June 30, 2014
OrbiMed Advisors 350000 $43.16M March 31, 2012
LPL Financial 319571 $45.57M Sept. 30, 2012
Deutsche Bank Aktiengesellschaft 299660 $77.01M June 30, 2014
Arrowgrass Capital Partners 286600 $65.08M Dec. 31, 2013
Rathbones Brothers 276802 $8.89M March 31, 2014
Perceptive Advisors 269400 $46.84M June 30, 2013
DAVENPORT & CO 247785 $43.08M Sept. 30, 2013
MANAGED ACCOUNT ADVISORS 245449 $67.16M Sept. 30, 2014
SG Americas Securities 232907 $59.86M June 30, 2014

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company March 31, 2014 263339 $62.21M
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M
Neuberger Berman June 30, 2011 237104 $25.29M